carbidopa-levodopa
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPSULE, EXTENDED RELEASE, ORAL | 23.75 mg/95 mg; 36.25 mg/145 mg; 48.75 mg/195 mg; 61.25 mg/245 mg | |||||||||||
| TABLET, EXTENDED RELEASE, ORAL | 25 mg-100 mg; 50 mg-200 mg | |||||||||||
| TABLET, ORAL | 10 mg-100 mg; 25 mg-100 mg; 25 mg-250 mg |
| Top 100 Hospital Administered Drug | |
|---|---|
| Drug Name | Common Side Effects |
| carbidopa-levodopa |
|